{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/0185cea5-9e3b-4b82-a887-26f91f92765f/702453ea-de83-4a1e-a77a-d0ce744d113a?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Audio long-read: How COVID exposed flaws in evidence-based medicine","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f3b71a8cbe675f3cedcb/61b9f4097701000015817db5.jpg?height=200","description":"<p><strong>A deluge of trials has stress-tested the systems that produce evidence.</strong></p><p><br></p><p>Around the world, researchers have raced to test therapies to treat COVID-19. The speed and urgency of this task has revealed both the weaknesses in the collection and use of research-based evidence, and how well-run trials have helped save lives.</p><p><br></p><p>This is an audio version of our feature: <a href=\"https://www.nature.com/articles/d41586-021-01246-x?utm_source=naturepod&amp;utm_medium=podcast&amp;utm_campaign=shownotes\" rel=\"noopener noreferrer\" target=\"_blank\">How COVID broke the evidence pipeline</a></p>","author_name":"Springer Nature Limited"}